source
- Eli Lilly beats Q3 revenue forecasts, lifts full-year outlookEli Lilly reported third-quarter revenue of $24.4 billion, roughly $2 billion above analysts' expectations. The outperformance underscores the company's strong position, driven in part by its GLP-…
- Bristol Myers Squibb emphasizes pipeline strength and later-stage partnership focus amid patent cliff concernsBristol Myers Squibb used its latest earnings call to outline how it plans to address an upcoming patent cliff that threatens revenue from several key products. Executives said the company is rely…